6 ADVERSE REACTIONS The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Diabetic Retinopathy Complications [see Warnings and Precautions (5.3)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.5)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.6)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.7)] Hypersensitivity Reactions [see Warnings and Precautions (5.8)] Acute Gallbladder Disease [see Warnings and Precautions (5.9)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.10)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Dont mix it with other shots, like insulin, in the same syringe
Sonia Anand, a vascular medicine specialist and a professor of medicine and epidemiology at McMaster University
2 In clinical trials, permanent discontinuation of treatment due to adverse reactions was similar in patients treated with Wegovy HD and Wegovy 2.4 mg injection (Wegovy HD 5%, Wegovy 2.4 mg 5%, placebo 2%)
If you want to stop using a medication like Ozempic , it is important to consult your provider, as GLP-1 medications affect blood sugar levels
